Canada Life’s Verisk Analytics VRSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.9M Buy
120,465
+2,096
+2% +$425K 0.04% 333
2025
Q4
$26.5M Sell
118,369
-81,406
-41% -$18.4M 0.05% 311
2025
Q3
$49.7M Buy
199,775
+7,175
+4% +$1.97M 0.07% 246
2025
Q2
$60.1M Buy
192,600
+5,808
+3% +$1.76M 0.1% 196
2025
Q1
$55.7M Sell
186,792
-6,797
-4% -$1.96M 0.1% 193
2024
Q4
$53.3M Buy
193,589
+4,107
+2% +$1.14M 0.09% 194
2024
Q3
$50.9M Buy
189,482
+4,370
+2% +$1.18M 0.09% 210
2024
Q2
$49.9M Buy
185,112
+19,077
+11% +$4.67M 0.09% 201
2024
Q1
$39.2M Sell
166,035
-612
-0.4% -$147K 0.08% 240
2023
Q4
$39.6M Buy
166,647
+7,057
+4% +$1.67M 0.09% 228
2023
Q3
$37.7M Buy
159,590
+5,477
+4% +$1.29M 0.09% 220
2023
Q2
$35M Buy
154,113
+13,384
+10% +$2.81M 0.08% 243
2023
Q1
$27M Sell
140,729
-416
-0.3% -$75.3K 0.07% 289
2022
Q4
$25M Sell
141,145
-7,502
-5% -$1.32M 0.07% 292
2022
Q3
$25.3M Buy
148,647
+1,066
+0.7% +$199K 0.07% 277
2022
Q2
$25.6M Buy
147,581
+22,757
+18% +$4.24M 0.07% 288
2022
Q1
$28.2M Buy
124,824
+4,265
+4% +$841K 0.06% 325
2021
Q4
$27.5M Sell
120,559
-18,816
-14% -$4.11M 0.06% 336
2021
Q3
$28.1M Buy
139,375
+8,028
+6% +$1.56M 0.07% 307
2021
Q2
$22.9M Sell
131,347
-9,271
-7% -$1.64M 0.05% 364
2021
Q1
$24.7M Buy
140,618
+7,536
+6% +$1.38M 0.06% 339
2020
Q4
$27.6M Buy
133,082
+1,943
+1% +$378K 0.05% 346
2020
Q3
$24.3M Buy
131,139
+83
+0.1% +$15.2K 0.05% 332
2020
Q2
$22.2M Sell
131,056
-1,193
-0.9% -$189K 0.05% 337
2020
Q1
$18.6M Sell
132,249
-10,777
-8% -$1.69M 0.05% 328
2019
Q4
$21.2M Sell
143,026
-1,322
-0.9% -$196K 0.05% 370
2019
Q3
$22.8M Buy
144,348
+5,131
+4% +$796K 0.05% 352
2019
Q2
$20.4M Sell
139,217
-1,504
-1% -$212K 0.05% 378
2019
Q1
$18.7M Buy
140,721
+41,312
+42% +$5.03M 0.05% 342
2018
Q4
$10.3M Sell
99,409
-1,433
-1% -$168K 0.03% 451
2018
Q3
$12.2M Sell
100,842
-11,535
-10% -$1.34M 0.03% 463
2018
Q2
$12.1M Buy
112,377
+759
+0.7% +$80.8K 0.03% 480
2018
Q1
$11.6M Sell
111,618
-3,274
-3% -$327K 0.03% 479
2017
Q4
$11M Buy
114,892
+1,967
+2% +$178K 0.03% 500
2017
Q3
$9.29M Buy
112,925
+4,111
+4% +$341K 0.02% 541
2017
Q2
$9.17M Sell
108,814
-71
-0.1% -$5.75K 0.02% 537
2017
Q1
$8.82M Sell
108,885
-5,705
-5% -$468K 0.02% 529
2016
Q4
$9.33M Buy
114,590
+1,132
+1% +$92.8K 0.03% 498
2016
Q3
$9.21M Buy
113,458
+1,577
+1% +$130K 0.03% 508
2016
Q2
$9.05M Buy
111,881
+24,606
+28% +$1.93M 0.03% 502
2016
Q1
$6.97M Buy
87,275
+3,356
+4% +$245K 0.03% 502
2015
Q4
$6.45M Buy
83,919
+338
+0.4% +$25.7K 0.02% 508
2015
Q3
$6.19M Buy
83,581
+1,118
+1% +$83.4K 0.02% 497
2015
Q2
$5.99M Buy
82,463
+2,600
+3% +$191K 0.02% 567
2015
Q1
$5.69M Sell
79,863
-131,549
-62% -$8.88M 0.02% 579
2014
Q4
$13.6M Buy
211,412
+5,357
+3% +$334K 0.04% 370
2014
Q3
$12.6M Buy
206,055
+18,340
+10% +$1.15M 0.04% 381
2014
Q2
$11.2M Buy
187,715
+54,978
+41% +$3.29M 0.04% 401
2014
Q1
$7.91M Buy
132,737
+3,674
+3% +$233K 0.03% 468
2013
Q4
$8.53M Buy
129,063
+30,862
+31% +$2.03M 0.03% 449
2013
Q3
$6.36M Buy
98,201
+94,651
+2,666% +$5.97M 0.03% 497
2013
Q2
$212K Buy
+3,550
New +$212K ﹤0.01% 583

Other funds holding VRSK

Canada Life's VRSK Position: Q1 2026 in Review

Canada Life increased its Verisk Analytics (VRSK) stake by 1.8% in Q1 2026, buying an estimated $425K and bringing the position to 120,465 shares worth $22.9M. The position accounts for 0.04% of the portfolio, ranked #333.

Canada Life first reported a position in VRSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $60.1M in Q2 2025. 954 funds tracked by Wall St. Rank hold VRSK as of Q1 2026.

  • Canada Life held 120,465 shares of Verisk Analytics worth $22.9M as of Q1 2026.
  • Canada Life bought 2,096 Verisk Analytics shares in Q1 2026, an estimated $425K.
  • Verisk Analytics made up 0.04% of Canada Life's portfolio in Q1 2026, its #333 holding.
  • Canada Life first reported a position in Verisk Analytics in Q2 2013 and has held it in 52 quarters since.
  • Canada Life's Verisk Analytics position peaked at $60.1M in Q2 2025.
  • 954 funds tracked by Wall St. Rank held Verisk Analytics as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.